Search research articles
Contact Us
Filters
Showing results (621-630 of 645) with videos related to
Page
of 65
Sort By:
The Prostate
|
June 8, 2022
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups
Arnulf Stenzl, Russell Z Szmulewitz, Daniel Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2022
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
ACS Central Science
|
February 27, 2023
Open-Source Chromatographic Data Analysis for Reaction Optimization and Screening
Christian P Haas, Maximilian Lübbesmeyer, Edward H Jin, et al.
Cephalalgia : an International Journal of Headache
|
May 24, 2008
CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood
B de Vries, A H Stam, F Beker, et al.
European Urology
|
May 13, 2023
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES
Andrew J Armstrong, Taro Iguchi, Arun A Azad, et al.
Klinische Padiatrie
|
October 26, 2013
Genotype-phenotype and genotype-origin correlations in children with mediterranean fever in Germany - an AID-net study
M Jeske, P Lohse, T Kallinich, et al.
JAMA Network Open
|
May 7, 2025
Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial
Arun A Azad, Daniel P Petrylak, Taro Iguchi, et al.
Pediatric Rheumatology Online Journal
|
April 7, 2018
IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry)
M Bielak, E Husmann, N Weyandt, et al.
The Journal of Urology
|
July 9, 2026
Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum
Neal D Shore, Martin Gleave, Ugo De Giorgi, et al.
The Journal of Urology
|
July 9, 2026
Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum
Neal D Shore, Ugo De Giorgi, Ronald F Tutrone, et al.
Page
of 65
Search research articles
Search
Showing results (621-630 of 645) with videos related to
Sort By:
Page
of 65
The Prostate
|
June 8, 2022
The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups
Arnulf Stenzl, Russell Z Szmulewitz, Daniel Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2022
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
ACS Central Science
|
February 27, 2023
Open-Source Chromatographic Data Analysis for Reaction Optimization and Screening
Christian P Haas, Maximilian Lübbesmeyer, Edward H Jin, et al.
Cephalalgia : an International Journal of Headache
|
May 24, 2008
CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood
B de Vries, A H Stam, F Beker, et al.
European Urology
|
May 13, 2023
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES
Andrew J Armstrong, Taro Iguchi, Arun A Azad, et al.
Klinische Padiatrie
|
October 26, 2013
Genotype-phenotype and genotype-origin correlations in children with mediterranean fever in Germany - an AID-net study
M Jeske, P Lohse, T Kallinich, et al.
JAMA Network Open
|
May 7, 2025
Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial
Arun A Azad, Daniel P Petrylak, Taro Iguchi, et al.
Pediatric Rheumatology Online Journal
|
April 7, 2018
IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry)
M Bielak, E Husmann, N Weyandt, et al.
The Journal of Urology
|
July 9, 2026
Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum
Neal D Shore, Martin Gleave, Ugo De Giorgi, et al.
The Journal of Urology
|
July 9, 2026
Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum
Neal D Shore, Ugo De Giorgi, Ronald F Tutrone, et al.
Page
of 65